Systems and methods for measuring cell signaling protein activity
US-2024230643-A9 · Jul 11, 2024 · US
US9765321B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9765321-B2 |
| Application number | US-201414323678-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 3, 2014 |
| Priority date | Oct 10, 2006 |
| Publication date | Sep 19, 2017 |
| Grant date | Sep 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel promoters which are derived from P. pastoris pastoris which are inducible or repressible under specific growth conditions are provided. These promoters are useful for regulating the expression of a desired structural gene, e.g., a mammalian polypeptide. Particularly preferred is the use of these novel promoters to regulate gene expression in polyploidal yeast such as diploidal P. pastoris produced by mating or spheroplast fusion.
Opening claim text (preview).
What is claimed is: 1. An isolated nucleic acid sequence containing an enolase (ENOI) promoter derived from the P. pastoris ENOI gene having the nucleic acid sequence contained in SEQ ID NO:22, which when operably linked to a structural gene renders the expression of the gene methanol repressive, and which is operably linked to a heterologous structural gene. 2. The isolated nucleic acid sequence of claim 1 wherein said structural gene encodes a non-yeast protein. 3. The isolated nucleic acid sequence of claim 2 wherein the structural gene is a mammalian gene. 4. The isolated nucleic acid sequence of claim 2 wherein the structural gene encodes an antibody polypeptide. 5. A plasmid containing the isolated nucleic acid of claim 1 . 6. A plasmid containing the isolated nucleic acid of claim 2 . 7. A plasmid containing the isolated nucleic acid of claim 3 . 8. A plasmid containing the isolated nucleic acid of claim 4 . 9. A yeast cell comprising an isolated nucleic acid according to claim 1 , wherein the structural gene is other than ENO1. 10. A yeast cell comprising an isolated nucleic acid according to claim 1 , wherein the structural gene is a mammalian structural gene. 11. A yeast cell comprising an isolated nucleic acid according to claim 1 , wherein the structural gene is a sequence encoding an antibody polypeptide. 12. A yeast cell according to claim 9 which is a P. pastoris, Candida, Saccharomyces, Yarrowia, Kluyveromyces, Hansenula , or Schizosaccharomyces yeast cell. 13. The yeast cell of claim 9 which is a P. pastoris yeast cell. 14. The yeast cell of claim 12 which is polyploid. 15. The yeast cell of claim 13 which is polyploid. 16. A method of using a yeast cell according to claim 9 to produce the protein encoded by said structural gene under the regulatory control of said ENO1 promoter. 17. The method of claim 16 wherein the protein is a mammalian protein. 18. The method of claim 17 wherein the mammalian protein is an antibody, cytokine or growth factor.
using catalysts, e.g. selective catalysts · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
for yeasts · CPC title
Phosphopyruvate hydratase (4.2.1.11), i.e. enolase · CPC title
against the T-cell receptor (TcR)-CD3 complex · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.